Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 

1. STOCK NEWS: 

• Snap (SNAP) shares cratered after the company tempered expectations for Q2 revenue and EBITDA and the negative read on digital advertising dragged down peers like Meta Platforms (FB) and Alphabet (GOOGL) [more]
• Zoom Video (ZM) shares closed higher following last night's Q1 report [more]
  
• Best Buy (BBY) cut its FY23 earnings and revenue view in conjunction with its Q1 report [more]
  
• Ralph Lauren (RL) reported fiscal Q4 results, gave FY23 guidance and increased its quarterly cash dividend 9% [more]
  
• Abercrombie & Fitch (ANF) tumbled after reporting unexpected losses for Q1 and stating that they expect higher costs to remain a headwind through at least year-end [more]
  

2. WALL STREET CALLS: 

• Morgan Stanley upgrades Marqeta (MQ) to Overweight, sees attractive entry point [more]
• Snowflake (SNOW) upgraded to Buy into Q1 results at Rosenblatt [more]
  
• Atlantic downgrades Roblox (RBLX) on softening app trends, halves target [more]
  
• Barclays downgraded Eaton (ETN) to Underweight from Equal Weight [more]
  
• Several analysts initiated coverage of HilleVax (HLVX) with a Buy or equivalent ratings [more]
  

3. AROUND THE WEB: 

• Dexcom (DXCM) in talks to acquire diabetes-device company Insulet (PODD), Bloomberg says [more]
• Carnival (CCL) in talks to sell Seabourn to Saudi sovereign wealth fund, CNBC reports [more]
  
• Oatly Group (OTLY) lining up eventual CEO successor, WSJ reports [more]
  
• Broadcom (AVGO) deal for VMware (VMW) to be structured as 50/50 cash and stock split, CNBC says [more]
  
• SpaceX President Shotwell defends Musk over misconduct claims, CNBC reports [more]
  

4. MOVERS: 

• MannKind (MNKD) up after the FDA approved partner United Therapeutics' (UTHR) Tyvaso DPI inhalation powder [more]
• Roivant Sciences (ROIV) higher after subsidiary Dermavant Sciences announced the FDA approved VTAMA cream [more]
  
• Frontline (FRO) gains in New York after reporting quarterly results [more]
  
• Fisker (FSR) lower after filing to sell up to $350M in stock [more]
  
• SpringWorks Therapeutics (SWTX) declines after reporting results from Phase 3 DeFi study of nirogacestat in desmoid tumors [more]
  

5. EARNINGS/GUIDANCE: 

• Nautilus (NLS) gave a FY23 revenue forecast below consensus [more]
• Albemarle (ALB) raised its FY22 adjusted EPS view and net cash from operations forecast [more]
  
• Advance Auto Parts (AAP) reported Q1 results and raised its FY22 EPS view [more]
  
• Honeywell (HON) reaffirmed its Q2 and FY22 adjusted EPS view [more]
  
• Petco (WOOF) reported better-than-expected Q1 results and backed its FY22 adjusted EPS view [more]
  

INDEXES: 

The Dow rose 48.38, or 0.15%, to 31,928.62, the Nasdaq lost 270.83, or 2.35%, to 11,264.45, and the S&P 500 declined 32.27, or 0.81%, to 3,941.48.